Injectable Therapeutic Hydrogel with H2O2 Self‐Supplying and GSH Consumption for Synergistic Chemodynamic/Low‐Temperature Photothermal Inhibition of Postoperative Tumor Recurrence and Wound Infection

Postoperative tumor recurrence and wound infection remain significant clinical challenges in surgery, often requiring adjuvant therapies. The combination treatment of photothermal therapy (PTT) and chemodynamic therapy (CDT) has proven to be effective in cancer treatment and wound infection. However, the hyperthermia during PTT increases the risk of normal tissue damage, severely impeding its application. Moreover, the efficacy of CDT is limited by insufficient hydrogen peroxide (H2O2) and excessive glutathione (GSH) levels at tumor or infection sites. Herein, an injectable and multifunctional CuO2@Au hydrogel system (CuO2@Au Gel) is developed for synergistic CDT and low‐temperature PTT (LTPTT) to prevent tumor recurrence and bacterial wound infections. CuO2@Au Gel is constructed by embedding therapeutic CuO2@Au into low‐melting point agarose hydrogel. In vitro and in vivo experiments confirm that the CuO2@Au in CuO2@Au Gel is capable of self‐supplying H2O2 and depleting GSH, exhibiting effective CDT effect in acidic tumor or bacterial infected microenvironment. Additionally, it exhibits favorable photothermal conversion ability, inducing localized temperature elevation and synergistically enhancing CDT efficiency. The prepared CuO2@Au Gel demonstrates efficient tumor ablation capability in post‐surgery recurrence mouse models and exhibits promising anti‐infective efficiency in bacterial infection wound models, indicating significant potential in adjuvant therapy for post‐surgical treatment and recovery. A multifunctional and injectable nanocomposite hydrogel (CuO2@Au Gel) with H2O2 self‐supplying and GSH‐depleting capabilities is created by simply adding core‐shell structured CuO2@Au nanomaterial to low‐melting agarose hydrogel. This produced an effective CDT/LTPTT effect, favorably inhibiting wound infection and postoperative tumor recurrence.